European Journal of Cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

European Journal of Cancer
Apr 23, 2025, 10:42 | Science
Federico Monaca: Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemo IO
Federico Monaca, Senior Clinical Research Fellow at The Christie NHS Foundation Trust, shared an article on…
Apr 6, 2025, 14:06 | Blog
Molecular Hyperselection for Optimal First-Line Targeted Therapy in RAS Wild-Type Metastatic Colorectal Cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared an article…
Mar 30, 2025, 16:06 | Blog
Anant Madabhushi: New Publication on AI-Driven Virtual Staining for Tumor-Associated Macrophages
Anant Madabhushi, Founding director of the Emory Empathetic AI for Health Institute, posted on LinkedIn…
Mar 24, 2025, 17:27 | Science
A checklist for the discussants of clinical trials at major cancer meetings - Common Sense Oncology
Common Sense Oncology shared a post on X about a paper by Elizabeth Eisenhauer et…
Mar 15, 2025, 15:45 | Science
Angela Lamarca: 5FU-based Adjuvant chemotherapy for Biliary Malignancies
Angela Lamarca, Consultant Medical Oncologist at Jiménez Díaz Foundation University Hospital and The Christie NHS…
Feb 21, 2025, 14:08 | Science
Survival improvement of patients with melanoma brain or leptomeningeal metastases in Denmark - CCIT-DK
CCIT-DK - National Center for Cancer Immune Therapy of Denmark shared an article by Sidsel…
Jan 15, 2025, 05:37 | Insight
Addressing the role of surgery in brain tumour trials - EANO
EANO shared a post on X, about a paper by Johnny Duerincka et al. published…
Dec 3, 2024, 13:09 | Insight
Khalid El Bairi: Our TASMAN study on the use of medical cannabis in oncology
Khalid El Bairi, Founder of The Cancer Biomarkers Working Group, shared a post on LinkedIn…
Nov 10, 2024, 00:33 | Insight
Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer
Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on…
Nov 4, 2024, 15:50 | Insight
Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer
Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on…
Nov 2, 2024, 21:32 | Insight
Shushan Hovsepyan: Are we overestimating the true benefits of cancer drugs?
Shushan Hovsepyan, Editor-in-Chief of the OncoDaily Medical Journal, shared a post on LinkedIn about a recent…
Oct 30, 2024, 02:44 | Blog
Mario Mandala: Incidence and mortality of adolescent and young adult melanoma patients
Mario Mandala posted on LinkedIn: "Our manuscript reporting the incidence and mortality of adolescent and…
Oct 29, 2024, 15:33 | Blog
EORTC - How EU regulations are not adequately supporting the conduct of patient-centred clinical trials
EORTC shared on LinkedIn: "A new EORTC article in the European Journal of Cancer highlights how…
Oct 22, 2024, 13:59 | Insight
Simeone D'Ambrosio: Differences in PFS assessment by BICR and local investigators
Simeone D'Ambrosio, Oncology Resident, shared a post on X about his recent paper published in…
Oct 19, 2024, 12:31 | Insight
A new publication from the EORTC Quality of Life and Head and Neck Cancer Groups
EORTC - European Organisation for Research and Treatment of Cancer, shared a post on LinkedIn…
Oct 15, 2024, 17:29 | Blog
Jill Feldman: Interesting finding for people with EFGR lung cancer that transforms to SCLC
Jill Feldman shared a post on X by Stephen V Liu adding: "Very interesting finding…
Oct 14, 2024, 13:40 | Insight
Retrospective report on EGFR mutant NSCLC transformed to SCLC, suggested by Stephen V Liu
Stephen V Liu shared a post on X: "Retrospective report in European Journal of Cancer on…
Oct 6, 2024, 13:07 | Blog
Shushan Hovsepyan: Challenges faced by adolescents with cancer in Italy
Shushan Hovsepyan shared on LinkedIn: "New Article Alert in the European Journal of Cancer. A…
Aug 17, 2024, 16:35 | Career
Matti Aapro is running for the UICC Board of Directors
It is our honor to announce that the Chair of the Editorial Board of the…
Aug 2, 2024, 02:02 | Blog
Sergio Cifuentes Canaval: Impact of CDK4/6 Inhibitors on Brain Metastases in HR+/HER2- Metastatic Breast Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…
Jul 30, 2024, 13:26 | Insight
Françoise Meunier: Protecting Cancer Survivors from Financial Discrimination Throughout the EU
Françoise Meunier shared a post on LinkedIn about her recent paper. "I am pleased to…
Jul 24, 2024, 13:28 | Blog
Ruzanna Papyan: The significant role of anti-GD2 therapy in the treatment of relapsed or refractory neuroblastoma
Ruzanna Papyan shared a post on LinkedIn about a recent paper by Patricia Raiser et al., commenting:…
Jul 5, 2024, 15:41 | Insight
Development of an EORTC QoL module for patients with advanced melanoma
EORTC Quality of Life Group (QLG) shared on X: “We are pleased to inform you…
Jun 30, 2024, 10:58 | Insight
Eleonora Nicolò: Our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age
Eleonora Nicolò, Research Fellow at Weill Cornell Medicine, shared a post on X: "Just out…
Jun 12, 2024, 06:21 | Insight
Massimo Di Maio: The Italian PRO4All Project
Massimo Di Maio, Medical Oncologist at Molinette Hospital, Turin, shared on X: "Have a look…
May 28, 2024, 04:25 | Insight
Arndt Vogel: A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas
Arndt Vogel shared on X: “A randomized phase II trial of Captem or Folfiri as…
Apr 18, 2024, 16:36 | Insight
New Paper Alert! Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy
Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy Authors: Pierre-Louis Cariou,…
Apr 18, 2024, 11:57 | Insight
New Paper Alert! The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based on Microsatellite Instability Status
The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based…
Mar 26, 2024, 13:13 | Blog
Timothée Olivier: Important findings for health policy
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, recently shared on X/Twitter: “Out…
Mar 15, 2024, 15:29 | Insight
Pablo Berlanga Charriel: The French real-world experience on chemo-immunotherapy in patients with relapsed/progressive high-risk neuroblastoma
Pablo Berlanga Charriel, Pediatric Oncology Consultant at Gustave Roussy, posted on LinkedIn: "I am very…
Jan 18, 2024, 16:11 | Insight
Erman Akkus: GIMs should be suspected in case of anemia or GI bleeding in patient with a history of RCC
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Gastrointestinal metastasis (GIM) of…
Oct 20, 2023, 20:15 | Blog
Alexander Sherry: P values have no place in the Table 1 of oncology RCTs
Alexander Sherry, Radiation Oncologist at MD Anderson Cancer Center, posted on his Twitter: "P values…
Sep 28, 2023, 17:51 | Insight
Diogo Martins Branco: Meta-analysis of Ki-67 prognostic value after neoadjuvant endocrine therapy.
Quoting Diogo Martins Branco, Medical Oncologist at the European Society of Medical Oncology, on LinkedIn:…
Aug 4, 2023, 15:17 | Blog
New ACCELERATE article published in the European Journal of Cancer - ACCELERATE Multi-Stakeholder Platform
New ACCELERATE article published in the European Journal of Cancer! Paediatric Strategy Forum for medicinal…
All: 34 Posts: 1 - 100
Special Coverage